134 related articles for article (PubMed ID: 16237054)
1. Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice.
Bour-Jordan H; Thompson HL; Bluestone JA
J Immunol; 2005 Nov; 175(9):5649-55. PubMed ID: 16237054
[TBL] [Abstract][Full Text] [Related]
2. Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.
Bour-Jordan H; Thompson HL; Giampaolo JR; Davini D; Rosenthal W; Bluestone JA
J Autoimmun; 2013 Sep; 45():58-67. PubMed ID: 23850635
[TBL] [Abstract][Full Text] [Related]
3. Divergent effects of T cell costimulation and inflammatory cytokine production on autoimmune peripheral neuropathy provoked by Aire deficiency.
Zeng XL; Nagavalli A; Smith CJ; Howard JF; Su MA
J Immunol; 2013 Apr; 190(8):3895-904. PubMed ID: 23487421
[TBL] [Abstract][Full Text] [Related]
4. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
5. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
6. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice.
Salomon B; Rhee L; Bour-Jordan H; Hsin H; Montag A; Soliven B; Arcella J; Girvin AM; Padilla J; Miller SD; Bluestone JA
J Exp Med; 2001 Sep; 194(5):677-84. PubMed ID: 11535635
[TBL] [Abstract][Full Text] [Related]
7. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
Lenschow DJ; Ho SC; Sattar H; Rhee L; Gray G; Nabavi N; Herold KC; Bluestone JA
J Exp Med; 1995 Mar; 181(3):1145-55. PubMed ID: 7532678
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
10. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.
Amrani A; Verdaguer J; Anderson B; Utsugi T; Bou S; Santamaria P
J Clin Invest; 1999 Apr; 103(8):1201-9. PubMed ID: 10207172
[TBL] [Abstract][Full Text] [Related]
11. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.
Kägi D; Odermatt B; Seiler P; Zinkernagel RM; Mak TW; Hengartner H
J Exp Med; 1997 Oct; 186(7):989-97. PubMed ID: 9314549
[TBL] [Abstract][Full Text] [Related]
12. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
13. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
[TBL] [Abstract][Full Text] [Related]
15. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
[TBL] [Abstract][Full Text] [Related]
16. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
Bergmann CC; Parra B; Hinton DR; Chandran R; Morrison M; Stohlman SA
J Immunol; 2003 Mar; 170(6):3204-13. PubMed ID: 12626579
[TBL] [Abstract][Full Text] [Related]
17. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.
Martins TC; Aguas AP
Clin Exp Immunol; 1999 Feb; 115(2):248-54. PubMed ID: 9933449
[TBL] [Abstract][Full Text] [Related]
19. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
